Overview

To Evaluate the Efficacy and the Safety of Monthly Versus Weekly Oral Risedronate With Vitamin D in Compliance, Improvement of Vitamin D and BMD in Korean Postmenopausal Osteoporotic Women

Status:
Completed

Trial end date:
2016-03-31

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the Efficacy and the Safety of Monthly(RisenexM group) versus Weekly Oral risedronate(Risenexsplus group) in Korean postmenopausal osteoporotic women(Phase IV)

Phase:

Phase 4

Details

Lead Sponsor:

Hanlim Pharm. Co., Ltd.

Treatments:

Cholecalciferol
Ergocalciferols
Etidronic Acid
Risedronate Sodium
Risedronic Acid
Vitamin D
Vitamins